摘要
通过查阅国内外相关文献,对急性冠脉综合征药物干预策略进行综合评析,综述急性冠脉综合征药物干预策略的药物经济学评价结果,得出具有成本-效果优势的药物干预策略,但仍需进一步深入研究。
The pharmacoeconomics research literatures were searched and collected , and which were then evaluated systematically to summarize the pharmacoeconomics evaluation results of acute coronary syndromes pharmacotherapy .Some cost-saving pharmacotherapies are given, but further study is needed.
出处
《中国药物评价》
2014年第3期189-192,共4页
Chinese Journal of Drug Evaluation
关键词
急性冠脉综合征
药物经济学
综述
Acute coronary syndromes
Pharmacoeconomics
Review
